4791-21-3

Basic information

• Product Name: chloroacetyl-ure
• Synonyms: chloroacetyl-ure;chloroacetylurea;n-(aminocarbonyl)-2-chloro-acetamid;N-aminocarbonyl-2-chloro-ethanamide;N-carbamoyl-2-chloroacetamide;N-carbamoyl-2-chloro-acetamide;AcetaMide,N-(aMinocarbonyl)-2-chloro-
• CAS NO: 4791-21-3
• Molecular Formula: C₃H₅ClN₂O₂
• Molecular Weight: 136.537
• Mol File: 4791-21-3.mol
• Article Data: 6

Chemical Properties

• Boiling Point: °Cat760mmHg
• Flash Point: °C
• Appearance: /
• Density: 1.419g/cm³
• Refractive Index: 1.493
• CAS DataBase Reference: chloroacetyl-ure(CAS DataBase Reference)
• NIST Chemistry Reference: chloroacetyl-ure(4791-21-3)
• EPA Substance Registry System: chloroacetyl-ure(4791-21-3)

Safety Data

• Hazardous Substances Data: 4791-21-3(Hazardous Substances Data)

Usage

General Description

Chloroacetyl-urea, also known as 2-chloroacetylamino-imidazolidinone, is a chemical compound used in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. It is a white crystalline solid with a molecular formula of C3H5ClN2O2 and a molecular weight of 134.54 g/mol. Chloroacetyl-urea is primarily used as an intermediate in the production of various pesticides and herbicides, as well as in the formulation of pharmaceutical drugs. It is a versatile chemical with a range of applications in the chemical industry, making it an important compound for various industrial processes. However, it is important to handle chloroacetyl-urea with caution, as it can be toxic and hazardous if not properly managed and utilized.

InChI:InChI=1/C3H5ClN2O2/c4-1-2(7)6-3(5)8/h1H2,(H3,5,6,7,8)

Upstream product

• 4461-30-7 2-chloroacetylisocyanate 
• 79-04-9 chloroacetyl chloride 
• 57-13-6 urea 
• 79-11-8 chloroacetic acid 

Downstream Products

• 5827-10-1 (dimethoxythiophosphorylsulfanyl-acetyl)-urea 
• 124-38-9 carbon dioxide 
• 556-90-1 pseudothiohydantoin 
• 626-36-8 ethyl allophanate 
• 67172-14-9 iodoacetyl-urea 
• 93249-29-7 benzenesulfonylacetyl-urea 
• 2425-16-3 (diethoxythiophosphorylsulfanyl-acetyl)-urea 
• 61893-09-2 1-ethylimidazolidine-2,4-dione 

Relevant articles and documents

11,13-MODIFIED SAXITOXINS FOR THE TREATMENT OF PAIN

Provided herein are compounds, pharmaceutical compositions comprising the compounds, methods of preparing the compounds, and methods of using the compounds and compositions in treating conditions associated with voltage-gated sodium channel function where the compounds are 11,13-modified saxitoxins according to Formula (I): where R4, R4a, R7, R7a, and X2 are as described herein.

TREATMENT OF DISEASES BY EPIGENETIC REGULATION

The present disclosure provides non-naturally occurring polyphenol compounds that inhibit the bromodomain and extra terminal domain (BET) proteins. The disclosed compositions and methods can be used for treatment and prevention of diseases or disorders that are susceptible to administration of a BET inhibitor.

Novel peptidomimetics of the antifungal cyclic peptide rhodopeptin: Synthesis of mimetics and their antifungal activity

(matrix presented) Novel peptidomimetics of the antifungal cyclic peptide Rhodopeptin were synthesized. As with the cyclic peptides, the presence of all three Rhodopeptin side chains was found to be indispensable for peptidomimetic activity. We discovered